Product Introduction Fulvestrant Injection 250mg/5mL is a sterile hormonal anticancer medicine used in the treatment of selected hormone receptor-positive breast cancers. It belongs to the estrogen receptor antagonist (SERD) class and works by blocking and reducing estrogen receptors that may promote the growth of certain breast cancer cells. Product Profile Specification Details Generic Name:Fulvestrant Strength:250mg/5mL Dosage Form:Sterile Injection Medicine Category:Hormonal Anticancer Medicine Drug Class:Selective Estrogen Receptor Degrader (SERD) Route of Administration:Intramuscular Injection Prescription Status:Prescription Only Primary Users:Hospitals & Oncology Centers Export Availability:Bulk & Commercial Supply Country of Origin: India In Case of Emergency or Overdose Seek immediate medical attention. Monitor the patient for worsening adverse effects and overall clinical condition. Supportive medical care should be provided based on symptoms. Inform the treating oncologist about the amount administered and the timing of the dose. Patients should never attempt to self-inject or adjust treatment schedules. Other Uses for This Medicine Besides its approved indications, healthcare professionals may consider Fulvestrant for certain specialized treatment strategies based on current clinical guidelines and patient-specific factors. In some cases, oncologists may combine it with other targeted anticancer medicines where clinically appropriate. What Side Effects Can This Medication Cause?: Frequently Reported Effects Injection-site discomfort Nausea Fatigue Headache Joint or muscle pain Mild weakness Unusual bleeding Persistent swelling of the legs Difficulty breathing or chest discomfort Global Demand for Hormonal Oncology Medicines Continues to Rise: Breast cancer treatment programs continue expanding worldwide, increasing procurement of hormone-based injectable medicines across North America, Europe, the Middle East, and Asia-Pacific. Frequently Asked Questions 1. What is Fulvestrant Injection 250mg/5mL primarily used for? It is prescribed for selected patients with hormone receptor-positive breast cancer as part of specialist-directed hormonal treatment. 2. Who should administer Fulvestrant Injection? Only qualified healthcare professionals should administer the injection in hospitals or oncology clinics. 3. Can hospitals order Fulvestrant Injection in bulk? Yes. Licensed hospitals, oncology centers, pharmaceutical distributors, and government procurement agencies may purchase commercial quantities subject to applicable regulations. 4. What export documents are generally available? Eligible international orders may include documents such as the Certificate of Analysis (COA), Certificate of Origin (COO), Commercial Invoice, Packing List, and other export-related documentation. 5. Why is India a preferred source for Fulvestrant Injection? India is recognized for high-quality pharmaceutical manufacturing, competitive pricing, scalable production capacity, and reliable international export support. -Buy Fulvestrant Injection 250mg 5mL Online -Fulvestrant Injection Supplier USA -Fulvestrant Exporter India -Hormonal Cancer Injection Supplier -Breast Cancer Medicine Export -Fulvestrant Wholesale Distributor -Oncology Injection Supplier -Injectable Breast Cancer Medicine -Pharmaceutical Export Company India -Hospital Oncology Procurement 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Procurement 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #FulvestrantInjection #Fulvestrant250mg #BreastCancerMedicine #HormonalTherapy #OncologyInjection #CancerCare #USAHealthcare #WashingtonDCMedical #HospitalProcurement #IndianPharmaExporter #GlobalPharma #BulkMedicineSupplier #HealthcareDistribution #OncologySupplier #MedicalExports #CancerTreatment #PharmaceuticalExporter #WorldwideHealthcare #LicensedMedicineSupplier #ErnestPharmaceutical

Therapeutic Role Many breast cancer cells depend on estrogen to support their growth. Exemestane permanently inactivates the aromatase enzyme responsible for producing estrogen after menopause. This lowers estrogen availability and may slow or suppress the growth of hormone-sensitive cancer cells. Safety Advice Medical supervision: Exemestane should be taken only according to the prescribing oncologist’s directions. Patients should not change the dose, discontinue therapy or restart treatment without medical advice. Pregnancy: Exemestane can harm an unborn baby and is not intended for use during pregnancy. Patients who may become pregnant should discuss effective contraception and pregnancy testing requirements with their doctor. Breastfeeding: Breastfeeding is generally not recommended during treatment and for the period specified by the treating physician after the final dose. Bone health: Lower estrogen levels can reduce bone-mineral density and increase the risk of osteoporosis or fractures. Doctors may evaluate bone health before and during long-term therapy. Liver and kidney conditions: Clinical monitoring may be required even when a routine dose adjustment is not prescribed. Vitamin D assessment: Patients with low vitamin D levels may require assessment or supplementation based on their clinician’s advice. Storage and Handling: Store the tablets at the temperature stated on the approved product label. Keep them in their original, tightly closed packaging. Keep it away from children and unauthorized persons. Do not use tablets that are expired, broken, contaminated or stored incorrectly. FAQs 1. What are Exemestane Tablets 25mg prescribed for? They are prescribed for selected postmenopausal women with estrogen-sensitive early or advanced breast cancer, particularly within treatment plans involving previous tamoxifen therapy. 2. Is Exemestane a chemotherapy medicine? Exemestane is classified as endocrine or hormonal therapy rather than conventional cytotoxic chemotherapy. It reduces estrogen production by permanently blocking the aromatase enzyme. 3. How should Exemestane Tablets be taken? The approved prescribing information recommends one 25mg tablet once daily after a meal, but patients must follow the exact instructions given by their oncology specialist. 4. Can Exemestane affect bone strength? Yes. Long-term estrogen reduction may decrease bone-mineral density, so the healthcare provider may recommend bone-health monitoring and preventive measures. 5. Can importers order Exemestane Tablets in bulk? Licensed importers, hospitals and authorized distributors may request commercial quantities, subject to product availability, prescription-drug regulations and the importing country’s approvals. Description Source Exemestane Tablets 25mg from an Indian pharmaceutical exporter for licensed buyers in Jamaica and Indonesia. Bulk supply and export documentation available. 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Procurement 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #ExemestaneTablets25mg #ExemestaneSupplier #BreastCancerMedicine #HormonalCancerTherapy #AromataseInhibitor #OncologyMedicineExporter #PharmaceuticalExporterIndia #KingstonPharmaSupply #JamaicaHealthcare #JakartaPharmaImporter #IndonesiaOncology #BulkMedicineSupplier #HospitalPharmaceuticalSupply #CancerCareProcurement #InternationalPharmaTrade #LicensedMedicineImporter #OncologyTabletDistributor #GlobalHealthcareSupply #IndianPharmaExporter #ErnestOncology

Affordable Bicalutamide 50mg Tablets Exporter Product Profile Feature Details Generic Medicine Bicalutamide Available Strength 50 mg Tablets Therapeutic Class Non-Steroidal Anti-Androgen Administration Oral Intended Users Hospitals, Oncology Clinics & Licensed Distributors Export Availability Bangkok (Thailand), Abu Dhabi (UAE) & Worldwide Clinical Role in Prostate Cancer Bicalutamide is prescribed to reduce the influence of male hormones (androgens) that contribute to prostate cancer growth. It is commonly introduced as part of hormone deprivation therapy and may be used alongside other approved treatments depending on the patient's clinical status. Patients Who May Receive This Medicine Healthcare professionals may prescribe Bicalutamide for: Hormone-sensitive prostate cancer Advanced or metastatic prostate cancer Combination treatment with GnRH/LHRH therapy Long-term endocrine management where clinically appropriate Treatment selection depends entirely on the oncologist's evaluation. Expected Treatment Benefits Patients receiving appropriate therapy may benefit from: Suppression of androgen activity Slower progression of hormone-dependent prostate cancer Oral tablet convenience without injection Compatibility with several established prostate cancer treatment protocols Long-term disease management under medical supervision If Too Many Tablets Are Taken An excessive amount of Bicalutamide may increase the possibility of unwanted reactions such as weakness, dizziness, stomach discomfort, or abnormal liver function. Patients should immediately contact a physician or poison centre if an overdose is suspected. There is no specific reversal medicine, therefore treatment generally focuses on observation and supportive care according to the patient's condition. Why Pharmaceutical Buyers Prefer Indian Supply Indian manufacturers continue supplying international markets because they offer: ✓ Consistent manufacturing quality ✓ GMP production facilities ✓ Commercial export quantities ✓ Competitive international pricing ✓ Documentation for regulated markets ✓ Reliable shipment scheduling FAQs 1. Can distributors order commercial quantities? Yes. Bulk supply is available for licensed pharmaceutical businesses. 2. Is Bicalutamide supplied in tablet form? Yes. This product is supplied as oral tablets. 3. Can hospitals request quotations? Yes. Commercial quotations are available for hospitals and procurement agencies. 4. Does every patient receive the same treatment plan? No. Therapy is individualized according to the treating oncologist. 5. Can exporters provide shipment documentation? Yes. Commercial export documents are provided according to destination-country requirements. 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Distributor | Bulk Supplier | Exporter 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #Bicalutamide50mg #HormonalOncology #ProstateCancerDrug #AntiAndrogenTherapy #GenericCancerMedicine #HospitalMedicine #BulkPharmaceuticals #GlobalDrugSupply #MedicineExporterIndia #WHOPharma #CancerTabletSupplier #BangkokHealthcare #UAEPharma #OncologyDistribution Generic Bicalutamide Manufacturer Bicalutamide 50mg Export Supplier Anti-Androgen Tablet Export Prostate Cancer Drug Manufacturer Oncology Tablet Wholesaler Pharmaceutical Export from India Hormonal Therapy Medicine Supplier Hospital Cancer Medicine Distributor Bicalutamide Commercial Supply

PRIMOXX 100 10ML Injection – Product Information Guide Description Learn about PRIMOXX 100 10ML Injection, containing Methenolone Enanthate 100mg/ml, including product profile, clinical-use overview, precautions, side effects, storage guidance, and regulatory information. PRIMOXX 100 10ML Injection PRIMOXX 100 10ML Injection contains Methenolone Enanthate 100mg/ml, an injectable anabolic-androgenic steroid formulation intended for use only under qualified medical supervision. It is administered by intramuscular route when prescribed by a healthcare professional for approved or clinically justified medical purposes. Key Product Information Brand Name: PRIMOXX 100 Generic Name: Methenolone Enanthate Strength: 100mg/ml Pack Size: 10ml Vial Dosage Form: Injection Therapeutic Category: Anabolic-Androgenic Steroid Route of Administration: Intramuscular Use: Prescription-based medical use only Clinical Indications & Usage Certain wasting or muscle-loss conditions Supportive anabolic therapy where clinically justified Selected cases requiring specialist-supervised anabolic support Other physician-determined medical needs Mechanism of Action: How PRIMOXX 100 Works Step-by-Step Action The injection is administered intramuscularly by a qualified professional. Methenolone Enanthate is gradually released into the bloodstream. The active compound interacts with androgen receptors. Protein metabolism and anabolic pathways may be influenced. Clinical response is monitored by a healthcare provider. Treatment is adjusted or stopped based on safety and medical need. Administration and Dosing Guide ministration Use only as prescribed by a qualified healthcare professional. Administration should be performed by trained medical personnel. Do not self-administer unless specifically trained and advised. Do not exceed the prescribed dose or treatment duration. Missed Dose If a scheduled dose is missed, contact the prescribing healthcare provider. Do not take an extra dose or change the schedule without medical advice. Safety, Side Effects, and Monitoring ommon Side Effects Acne or oily skin Fluid retention Headache Mood changes Changes in libido ossible Serious Side Effects Seek medical attention if any of the following occur: Severe allergic reaction Breathing difficulty Chest pain Possible Serious Side EffectsBreathing difficulty Chest pain Significant swelling Precautions: Before using PRIMOXX 100, inform your doctor if you have: Liver disease Heart disease Kidney problems High blood pressure Cholesterol abnormalities Hormonal disorders Prostate-related conditions History of mood disorders Any ongoing medication use Storage and Handling Specifications tore as per the product label instructions. Keep away from excessive heat, moisture, and direct sunlight. Keep the vial in original packaging until use. Do not freeze unless stated on the label. Keep out of reach of children. Regulatory and Compliance Documentation Certificate of Analysis, if available Product specifications Batch details Invoice and export documentation Manufacturer-related documents Quality and compliance records PRESCRIPTION MEDICINE IS : YES Disclaimer: PRIMOXX 100 10ML Injection is a prescription-only medicine and should be used only under qualified medical supervision. Product availability, usage, import/export, and documentation depend on local laws and regulatory requirements. This information is for educational and product reference purposes only and is not medical advice. Frequently Asked Questions 1. What is PRIMOXX 100 10ML Injection? : PRIMOXX 100 10ML Injection is an injectable product containing Methenolone Enanthate 100mg/ml. 2. What is methenolone enanthate? Methenolone enanthate is an anabolic-androgenic steroid compound used only under medical supervision where clinically appropriate. 3. Can PRIMOXX 100 be used without a prescription? : No. This product should be used only with valid medical guidance and according to local laws and prescription requirements. 4. Is PRIMOXX 100 used for bodybuilding? : PRIMOXX 100 should not be used for bodybuilding, athletic enhancement, or self-medication. Misuse of anabolic steroids can cause serious health risks. 5. How is PRIMOXX 100 administered? : It is intended for intramuscular administration by a qualified healthcare professional. Contact Ernest Oncology—Pharmaceutical Exporter Group of Ernest Pharmaceutical Pvt. Ltd. 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/91935990238

Discover Androfast 1% Gel (Testosterone 80g), a testosterone replacement therapy for male hypogonadism. Learn about its uses, application, benefits, and safety precautions. Androfast 1% Gel (Testosterone Gel 80g) Androfast 1% Gel is a topical medication formulated to assist in the treatment of male hypogonadism. It contains Testosterone (1% w/w), which acts as a replacement therapy to restore testosterone levels in men diagnosed with conditions associated with a deficiency or absence of endogenous testosterone. Product Profile: Understanding Androfast Gel Androfast is manufactured to assist men in maintaining healthy testosterone levels, which are vital for reproductive tissue development, muscle mass, bone density, and overall well-being. Key Product Information Brand Name: Androfast Composition: Testosterone USP (1% w/w) Strength: 1% Packaging Size: 80 g (Bottle/Pump) Dosage Form: Topical Gel Therapeutic Category: Androgen (Hormone Replacement) Route of Administration: Transdermal (Skin application) Clinical Indications & Usage Primary Hypogonadism: Conditions resulting from testicular failure (congenital or acquired). Hypogonadotropic Hypogonadism: Conditions resulting from pituitary or hypothalamic failure. Andropause: Managing symptoms associated with naturally declining testosterone levels in mature males. Mechanism of Action Androfast gel functions by supplementing the body's natural testosterone levels. When applied to the skin, the testosterone is absorbed into the bloodstream, helping to restore hormonal balance and alleviate symptoms associated with deficiency. Important Precautions :Avoid Transfer: Cover the application site with clothing to prevent secondary exposure to others, particularly women and children. Water Exposure: Follow physician instructions regarding swimming or showering after application. Sensitive Areas: Do not apply the gel to the genitals or irritated skin. Common Side Effects Application site reactions (redness, itching, or irritation) Acne Increased blood pressure Headache Storage and Handlingbelow Keep in the original packaging, away from heat and direct sunlight. Do not use after the expiry date. Why Choose Ernest Oncology Stringent Quality Reliable Supply Professional Expertise Contact Ernest Oncology—Pharmaceutical Medicine Exporter [Group of Ernest Pharmaceutical Pvt. Ltd.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

The Comprehensive Guide to Tamoxifen 10mg Tablets In the global fight against breast cancer, Tamoxifen 10mg Tablets remain one of the most widely used and effective hormonal therapies. As a premier pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this essential medication is accessible to patients and healthcare providers in London, New York, Sydney, Johannesburg, and beyond, adhering to the highest international quality standards. Product Specifications Brand Name: Ernest-Oncology (Tamoxifen Citrate) Concentration: 10mg per tablet Dosage Form: Oral Tablet Primary Indication: Treatment and prevention of hormone receptor-positive (ER+) breast cancer Storage: Store at 20°C to 25°C (68°F to 77°F), protected from light and moisture Mechanism of Action: How It Works Anti-Estrogenic (Breast Tissue): It competes with estrogen for binding sites on cancer cells. By blocking these receptors, it prevents estrogen from “signaling“ the cancer cells to grow and divide. Estrogenic (Bone and Lipids): Unlike chemotherapy, Tamoxifen can have beneficial effects on bone density in postmenopausal women and can help lower LDL cholesterol levels. Cytostatic Effect: It primarily works by slowing or stopping the cell cycle, making it an effective long-term maintenance therapy. Therapeutic Indications & Administration Early Breast Cancer: Used as adjuvant therapy after surgery and radiation to reduce the risk of recurrence. Metastatic Disease: A first-line treatment for hormone-sensitive breast cancer that has spread.Ductal Carcinoma in Situ (DCIS): Used to reduce the risk of invasive cancer following primary treatment. Chemoprevention: Prescribed for women at high risk of developing breast cancer. Administration: Typically taken once or twice daily, with or without food. It is recommended to take the medication at the same time each day to maintain steady blood levels. Clinical Side Effects & Safety Common Effects: Hot flashes, vaginal discharge, nausea, fatigue, and mood swings. Serious Warnings: * Thromboembolism: Increased risk of blood clots (DVT or pulmonary embolism). Endometrial Changes: Increased risk of uterine (endometrial) cancer; any abnormal vaginal bleeding should be reported immediately. Ocular Effects: Potential for cataracts or retinal changes with long-term use. Contraindications: Should not be used during pregnancy as it may cause fetal harm. Effective non-hormonal contraception is required during treatment. Why Source from Ernest Oncology? United Kingdom (London): Providing high-quality, cost-effective oncology alternatives for private hospitals and NHS-linked providers. USA: Delivering bulk supply solutions that meet stringent safety, documentation, and logistical benchmarks. Australia: Facilitating access to life-saving treatments through established “Special Access Scheme“ (SAS) supply chains. South Africa: Bridging the gap in cancer care with affordable, high-tier pharmaceutical exports from India. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] Business Type: Exporter | Bulk Supplier | Distributor Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com Email: exports@ernestpharmaceuticals.com WhatsApp/Call: +91 93599 02383 Direct Chat: Connect on WhatsApp

Eligard Injection (Leuprolide Acetate): Advanced ATRIGEL® Delivery for Prostate Cancer – Global Supply by Ernest Oncology In the oncology landscape of 2026, Eligard (Leuprolide Acetate) remains a gold-standard treatment for advanced prostate cancer. Utilizing the patented ATRIGEL® Delivery System, Eligard provides a unique polymeric matrix that solidifies upon subcutaneous injection, ensuring a controlled and sustained release of leuprolide acetate. As a potent Gonadotropin-Releasing Hormone (GnRH) agonist, it effectively induces medical castration, significantly reducing serum testosterone levels to suppress tumor growth. Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a leading Exporter, Bulk Supplier, and Distributor from India. We facilitate the international distribution of Eligard to the USA, UK, London, Abu Dhabi, Australia, and South Africa, providing validated logistics and comprehensive pharmaceutical documentation for global procurement. Technical Product Profile: Eligard 7.5mg / 22.5mg / 45mg Eligard is distinct from other leuprolide formulations due to its subcutaneous administration and varied dosing schedules, ranging from one to six months. Product Specifications Active Ingredient: Leuprolide Acetate. Delivery System: ATRIGEL® (Polymeric matrix for sustained release). Dosage Strengths: Available in 7.5 mg (1-month), 22.5 mg (3-month), 30 mg (4-month), and 45 mg (6-month) formulations. Mechanism of Action: GnRH Agonist; suppresses the hypothalamic-pituitary-gonadal axis to lower testosterone to castrate levels. Therapeutic Class: Antineoplastic Agent / LH-RH Agonist. Storage Requirements: Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Once mixed, it must be administered immediately. Primary Clinical Indications Advanced Prostate Cancer: Palliative treatment of advanced prostatic adenocarcinoma. Androgen Deprivation Therapy (ADT): Used as a primary hormonal intervention to slow the progression of hormone-sensitive prostate cancer. Key Features & Global Logistics Excellence Controlled Release Precision: The ATRIGEL® system ensures there are no significant “bursts“ of medication, maintaining stable castrate levels of testosterone over the entire dosing interval. Subcutaneous Convenience: Administered subcutaneously rather than intramuscularly, offering a less invasive option for long-term therapy. Superior Supply Chain Integrity: Ernest Oncology ensures that Eligard reaches oncology clinics in London, Abu Dhabi, or Sydney with strict temperature monitoring and optimal shelf-life. Regulatory Compliance: Every shipment includes a Certificate of Analysis (CoA) and adheres to international Good Distribution Practices (GDP), ensuring smooth customs clearance. Global Export Reach: USA, UK, UAE, Australia, & South Africa Ernest Oncology manages the complex regulatory requirements for exporting specialized hormonal therapies from India to major global healthcare hubs: USA: Supplying specialized urology centers and B2B wholesale distributors with authentic Eligard kits. UK & London: Supporting NHS Trusts and private oncology networks with reliable access to cost-effective hormonal treatments. Abu Dhabi, UAE: Catering to the advanced medical infrastructure of the Middle East with rapid and secure pharmaceutical delivery. Australia: Navigating TGA standards to provide Australian healthcare providers with authentic oncology medications. South Africa: Strengthening the Southern African oncology sector through consistent bulk supply and competitive pricing. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India (Group of Ernest Pharmaceutical Pvt. Ltd.) Partner with a verified leader for the bulk procurement of Eligard and specialized oncology medications. 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Instant Chat: https://wa.me/919359902383

Luprodex Injection: High-Efficacy Hormonal Therapy – Global Supply by Ernest Oncology In the advanced clinical landscape of 2026, Luprodex (Leuprolide Acetate) stands as a critical therapeutic agent for the management of hormone-responsive cancers and specialized gynecological conditions. As a synthetic analogue of the naturally occurring gonadotropin-releasing hormone (GnRH), Luprodex acts by suppressing the production of testosterone in men and estrogen in women, effectively inhibiting the growth of tumors that rely on these hormones to proliferate. Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a leading Exporter, Bulk Supplier, and Distributor from India. We facilitate the international distribution of Luprodex to the USA, UK, London, Abu Dhabi, Australia, and South Africa, providing validated logistics and comprehensive pharmaceutical documentation for global procurement. Technical Product Profile: Luprodex (Leuprolide Acetate) Luprodex is available in multiple formulations, including daily injections and long-acting depot versions, designed to provide flexible dosing schedules for various clinical needs. Product Specifications Active Ingredient: Leuprolide Acetate. Dosage Strengths: Available in 3.75 mg, 11.25 mg, and 22.5 mg formulations. Mechanism of Action: GnRH Agonist; induces a state of “medical castration“ by down-regulating pituitary GnRH receptors, leading to a significant decrease in LH and FSH levels. Therapeutic Class: Antineoplastic Agent / Hormone Therapy. Storage Requirements: Store at controlled room temperature (below 25°C). Do not freeze. Primary Clinical Indications Prostate Cancer: Indicated for the palliative treatment of advanced prostatic adenocarcinoma, forming a cornerstone of Androgen Deprivation Therapy (ADT). Endometriosis: Management of endometriosis-associated pain and reduction of endometrial lesions. Uterine Fibroids: Used to reduce the size of leiomyomata (fibroids) prior to surgical intervention. Central Precocious Puberty (CPP): Treatment of pediatric patients with early-onset puberty. Key Features & Global Logistics Excellence Targeted Hormone Suppression: Proven to lower serum testosterone to castrate levels (< 50 ng/dL) effectively within the first few weeks of therapy. Flexible Administration: Multiple strengths allow for monthly, 3-monthly, or 6-monthly dosing cycles, enhancing patient convenience. Superior Supply Chain Integrity: Ernest Oncology ensures that Luprodex reaches oncology clinics and hospitals in London, Abu Dhabi, or Sydney with optimal shelf-life and strict quality control. Regulatory Compliance: Every shipment is accompanied by a Certificate of Analysis (CoA) and adheres to international Good Distribution Practices (GDP), facilitating seamless customs clearance. Global Export Reach: USA, UK, UAE, Australia, & South Africa Ernest Oncology manages the complex regulatory requirements for exporting specialized hormonal therapies from India to major global healthcare hubs: USA: Reliable supply for urology clinics and oncology distributors seeking high-quality Leuprolide formulations. UK & London: Supporting NHS Trusts and private clinics with consistent access to essential hormonal treatments. Abu Dhabi, UAE: Catering to the advanced medical infrastructure of the Middle East with rapid and secure pharmaceutical delivery. Australia: Navigating TGA standards to provide Australian healthcare providers with authentic oncology medications. South Africa: Strengthening the Southern African oncology sector through consistent bulk supply and competitive pricing. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India (Group of Ernest Pharmaceutical Pvt. Ltd.) Partner with a verified leader for the bulk procurement of Luprodex and specialized oncology medications. 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Instant Chat: https://wa.me/919359902383

Lupride Depot Injection: Advanced Hormonal Therapy for Oncology – Global Supply by Ernest Oncology In the evolving therapeutic landscape of 2026, Lupride Depot (Leuprolide Acetate) remains a gold-standard treatment for hormone-sensitive malignancies and reproductive health conditions. As a potent Gonadotropin-Releasing Hormone (GnRH) agonist, Lupride Depot works through a dual-phase mechanism: initially stimulating and subsequently desensitizing the pituitary gland. This leads to a profound suppression of testosterone in men and estrogen in women, effectively “starving“ hormone-dependent tumors. Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a leading Exporter, Bulk Supplier, and Distributor from India. We facilitate the international distribution of Lupride Depot to the USA, UK, London, Abu Dhabi, Australia, and South Africa, providing validated logistics and comprehensive pharmaceutical documentation for global procurement. Technical Product Profile: Lupride Depot 3.75mg / 11.25mg / 22.5mg Lupride Depot is formulated as a lyophilized powder for microsphere-based sustained-release injection. This “Depot“ technology allows for consistent therapeutic drug levels over extended periods, ranging from one to six months depending on the dosage. Product Specifications Active Ingredient: Leuprolide Acetate. Dosage Strengths: Available in 3.75 mg (1-month), 11.25 mg (3-month), and 22.5 mg (6-month) depot formulations. Mechanism of Action: GnRH Agonist; induces medical castration by suppressing the hypothalamic-pituitary-gonadal axis. Therapeutic Class: Antineoplastic Agent / Hormone Therapy. Storage Requirements: Store at controlled room temperature (below 25°C). Do not freeze. Primary Clinical Indications Prostate Cancer: Palliative treatment of advanced prostatic adenocarcinoma; recognized as a primary tool in Androgen Deprivation Therapy (ADT). Endometriosis: Management of endometriosis, including pain relief and reduction of endometrial lesions. Uterine Fibroids: Preoperative treatment of patients with anemia caused by uterine leiomyomata (fibroids). Precocious Puberty: Treatment of central precocious puberty (CPP) in pediatric patients. Key Features & Global Logistics Excellence Sustained Release Precision: The microsphere technology ensures a steady release profile, reducing the frequency of injections and improving patient compliance. Clinically Validated Efficacy: Decades of clinical success in reducing serum testosterone to castrate levels (< 50 ng/dL) in prostate cancer patients. Superior Supply Chain Integrity: Ernest Oncology manages the end-to-end distribution, ensuring that Lupride Depot reaches oncology clinics in London, Abu Dhabi, or Sydney with optimal shelf-life and zero compromise in quality. Regulatory Compliance: Every shipment includes a Certificate of Analysis (CoA) and adheres to international Good Distribution Practices (GDP), ensuring smooth customs clearance. Global Export Reach: USA, UK, UAE, Australia, & South Africa Ernest Oncology manages the complex regulatory requirements for exporting specialized hormonal therapies from India to major global healthcare hubs: USA: Supplying specialized urology and oncology centers with authentic Leuprolide Depot formulations. UK & London: Supporting NHS Trusts and private oncology networks with reliable access to cost-effective hormonal treatments. Abu Dhabi, UAE: Catering to the advanced medical infrastructure of the Middle East with rapid, secure delivery. Australia: Navigating TGA standards to provide Australian healthcare providers with essential oncology medications. South Africa: Strengthening the Southern African medical sector through consistent bulk supply and competitive pricing. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India (Group of Ernest Pharmaceutical Pvt. Ltd.) Partner with a verified leader for the bulk procurement of Lupride Depot and specialized oncology medications. 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Instant Chat: https://wa.me/919359902383